Fig. 3From: The Glioma-IRE project − Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approachImpact of molecular profile on glioma outcome: Time to disease progression in patients with at least one SNV vs no SNV (A) and in patients with IDH1 SNV vs IDH1 WT (B)Back to article page